These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17853916)

  • 21. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
    Chung HJ; Uitto J
    Dermatol Clin; 2010 Jan; 28(1):93-105. PubMed ID: 19945621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
    Dayal JH; Cole CL; Pourreyron C; Watt SA; Lim YZ; Salas-Alanis JC; Murrell DF; McGrath JA; Stieger B; Jahoda C; Leigh IM; South AP
    J Cell Sci; 2014 Feb; 127(Pt 4):740-51. PubMed ID: 24357722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
    Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
    Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
    Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
    Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
    [No Abstract]   [Full Text] [Related]  

  • 27. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma.
    Lee CAA; Wu S; Chow YT; Kofman E; Williams V; Riddle M; Eide C; Ebens CL; Frank MH; Tolar J; Hook KP; AlDubayan SH; Frank NY
    J Invest Dermatol; 2024 Jul; 144(7):1534-1543.e2. PubMed ID: 38272206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development.
    Guerra L; Odorisio T; Zambruno G; Castiglia D
    Matrix Biol; 2017 Nov; 63():1-10. PubMed ID: 28126522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
    Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
    J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
    Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
    Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
    Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
    Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
    J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa.
    Vincent C; Lefort N; Hamlin M; Banal C; Hovnanian A; Izmiryan A
    Stem Cell Res; 2023 Jun; 69():103104. PubMed ID: 37148821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
    Windler C; Hermsdorf U; Brinckmann J; Seeger K
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):52-59. PubMed ID: 27989960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
    Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.